Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-03-22
2011-03-22
Wilson, Michael C. (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S093200
Reexamination Certificate
active
07910562
ABSTRACT:
A molecular delivery complex specific to antigen-presenting cells is formed from a non-viral gene delivery system complexed with foreign genetic material. The complex then enters the targeted cells through a specific receptor and overcomes the degradation mechanism, so that functional uptake of the foreign genetic material, or transduction, of the cell, results in gene expression. The invention also includes a method for genetic immunization without a needle.
REFERENCES:
patent: 5908923 (1999-06-01), Holler et al.
patent: 5916803 (1999-06-01), Sedlacek et al.
patent: 6013240 (2000-01-01), Behr et al.
patent: 6140114 (2000-10-01), Klatzmann et al.
patent: 6420176 (2002-07-01), Lisziewicz et al.
Stricker et al., Medical Hypotheses, Jun. 1997, vol. 48, p. 527-529.
Bangham, Nov. 29, 1997, Lancet, vol. 350, p. 1617-1621.
Miller 1995, FASEB J., vol. 9, p. 190-199.
Deonarain, 1998, Expert Opin. Ther. Pat., vol. 8, p. 53-69.
Verma, Sep. 1997, Nature, vol. 389, p. 239-242.
Adachi et al. J. Virol., 1986, vol. 59, pp. 284-291.
Owada et al. Microbiol. Immunol. Feb. 1998, vol. 242, No. 2, p. 97-107.
Diebold et al., Advances in Experimental Med. and Biol., Oct. 1998, vol. 451, pp. 449-455.
The preface of Advances in Experimental Med. and Biol., Oct. 1998, vol. 451 (p. v and vi).
Song (PNAS, Mar. 1997, vol. 94, p. 1943-1948.
On-line medical dictionary definition of “dendritic cell”.
Condon, Nature Med., 1996, vol. 2, No. 10, p. 1122-1128.
Tuting (J. Invest. Derm., 1998, vol. 111, p. 183-188.
Robinson (Vaccine, 1993, vol. 11, p. 957-960).
Fynan (PNAS, 1993, vol. 90, p. 11478-11482).
Lai (DNA and Cell Biol., 1995, vol. 14, No. 7, p. 643-651).
Ma (Acta virologica, 1996, vol. 40, p. 311-314).
Lisziewicz (J. Invest. Derm., Jan. 2005, vol. 124, No. 1, p. 160-169.
Lori, Current Meical and Chemical Anti-Infective Agents, 2004, vol. 3, p. 31-41.
Ready (Nature Medicine, (Apr. 2003, vol. 9, No. 4, p. 376).
Veljkovic (Vaccine, 2001, vol. 19, p. 1855-1862).
Hanke (Immunology Letters, 1999, vol. 66, p. 177-181).
Weber (Eur. J. Clin. Microbiol. Infect. Dis., Nov. 2001, vol. 20, p. 800-803).
Lori (Current Medical and Chemical Anti-Infective Agents, 2004, vol. 3, p. 31-41).
Dong (J. Exp. Med., Dec. 20, 2004, vol. 200, No. 12, p. 1547-1557).
Lisziewicz, J. Invest. Derm., Jan. 2005, vol. 124, No. 1, p. 160-169.
Lisziewicz (2001, J. Virol., Aug. 2001, vol. 75, No. 16, p. 7621-7628).
Mittal (J. General Virol., Jan. 1996, vol. 77, p. 1-9, abstract only).
Kuby, ed., Immunology, 1992, W.H. Freeman and Company, Chapter 1, “Acquired Immunity,” p. 8-9.
On-line medical dictionary definition of “toxicity”.
Online Medical dictionary definition of “immunogenic”.
McMichael, Annual Rev. Immunol., 1997, vol. 15, p. 271-296.
Definition of “apply” by Dictionary.com.
Kuby (ed., Immunology, 1992, W.H. Freeman and Company, Chapter 1, “Acquired Immunity,” p. 8-9).
Liu (Vaccine, 2002, vol. 20, p. 42-48).
Lisziewicz Julianna
Lori Franco
Genetic Immunity, LLC
Looper Valerie E.
Wilson Michael C.
LandOfFree
Method of delivering genes into antigen presenting cells of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of delivering genes into antigen presenting cells of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of delivering genes into antigen presenting cells of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2751073